Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2025-09-04 00:00:00 ET · period of report 2025-09-03 · accession 0000874015-25-000219 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-09-04 | 2025-09-03 | IONS | KLEIN JOSEPH III | Dir | M - OptEx | $0.00 | +28.0K | 16.0K | New | $0 |
| DI | 2025-09-04 | 2025-09-03 | IONS | KLEIN JOSEPH III | Dir | S - Sale+OE | $60.00 | -28.0K | 0 | -100% | -$1.68M |
| DMI | 2025-09-04 | 2025-09-03 | IONS | KLEIN JOSEPH III | Dir | M - OptEx | $0.00 | -28.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-03 | M | A | 12,000 | $0.00 | 28,000 | I by Trust | — | — | |
| 2 | Common | Common Stock | 2025-09-03 | M | A | 16,000 | $0.00 | 16,000 | I by Trust | — | — | |
| 3 | Common | Common Stock | 2025-09-03 | S | D | 28,000 | $60.00 | 0 | I by Trust | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 3, 2024 |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-09-03 | M | D | 12,000 | $0.00 | 0 | I by Trust | $42.88 · 2019-07-02 to 2028-07-01 | 12,000 Common Stock | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-09-03 | M | D | 16,000 | $0.00 | 0 | I by Trust | $52.22 · 2018-07-03 to 2027-07-02 | 16,000 Common Stock |